10003- MET-1 NEOADJUVANT STEREOTACTIC RADIOTHERAPY FOLLOWED BY SURGICAL RESECTION FOR BRAIN METASTASES: EFFICACY AND SAFETY STUDY (NEO-TACTICS TRIAL)

Koichi Mitsuya, Kazuya Motimura, Yuji Kibe, Takumi Otake · 2024

Read 10003- MET-1 NEOADJUVANT STEREOTACTIC RADIOTHERAPY FOLLOWED BY SURGICAL RESECTION FOR BRAIN METASTASES: EFFICACY AND SAFETY STUDY (NEO-TACTICS TRIAL) by Koichi Mitsuya, Kazuya Motimura, Yuji Kibe, Takumi Otake (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11605571.txt.

Description

Mitsuya, Motimura, Kibe, and Otake review twenty patients whose brain metastases were irradiated before surgery rather than after, in a 2024 report. Giving focused radiation first may sterilize tumor cells that surgery could spill, but its safety for large tumors removed piecemeal was unknown.

Patients received thirty or thirty-five units of radiation in five sessions, then surgery a median of four days later. Side effects during radiation were mild. Seventeen tumors came out completely. Only one local recurrence appeared, in a partially removed tumor, and one case of spread along the spinal fluid. No radiation damage to brain tissue occurred. A multi-center trial of the approach is now running.

Catalog record

CREATORKoichi Mitsuya, Kazuya Motimura, Yuji Kibe, Takumi Otake
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11605571

Browse the full library · About the Tower of Babel